• Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Blog
  • Contact
Nautilus Biotechnology
  • Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Blog
  • Contact

Why follow Nautilus on Twitter? A look back at Nautilus’ tweets in 2022

December 22, 2022
Tyler Ford
LinkedInTwitter

Scientists have a robust presence on Twitter and use the platform to regularly share new research, job listings, work milestones, and life milestones. In a similar vein, we’re on Twitter to get the word out about the proteomics revolution and to make people more aware of the many ways the Nautilus platform can transform basic research, drug development, and more.

 

This post features some of our most exciting tweets from 2022. By spotlighting these tweets, we hope to give you a taste of the ways we share information about our technology, our leadership, and our commitment to developing a diverse, cross-disciplinary, and robust scientific workforce.

 

Tweets focused on Nautilus’ Technology

We regularly tweet about recent developments surrounding our technology. These tweets cover publications about our platform, applications of the platform, popular news stories about Nautilus, and opportunities to use our technology. Here are a few of our favorite examples: 

Screenshot featuring a Tweet from the Nautilus Biotechnology Twitter account focused on Nautilus' collaboration with Genentech analyzing proteins involved in Alzheimer's disease.

 

We recently blogged about our ongoing collaboration with Genentech. We’re leveraging our platform to learn more about the proteins behind Alzheimer’s disease. 

Screenshot featuring a tweet from the Nautilus Biotechnology Twitter account. The tweet shares the Nautilus preprint demonstrating how we create nanoprobes from commercially available materials.

 

Last August, we shared a preprint demonstrating how we can use commercially available materials to create DNA nanoprobes to detect peptides and proteins. 

Screenshot of a tweet from the Nautilus Biotechnology Twitter account. This tweet focuses on Nautilus' recently announced "Firs Access Challenge."

 

In our “First Access Challenge,” scientists of all backgrounds are invited to submit proposals and gain early access to Nautilus’ Proteome Analysis Platform. Three winners will be able to analyze 12 samples on the platform free of charge and access proteomic discovery in a new way. 

Tweets focused on our founders’ vision for the proteomics revolution

Nautilus founders Sujal Patel and Parag Mallick were driven to create Nautilus because they believe in the power of the proteome to accelerate research, revolutionize healthcare, and improve lives. The tweets below highlight some of the ways Sujal and Parag have shared their vision for the proteomics revolution. 

Screenshot of a Tweet from the Nautilus Biotechnology Twitter account. This tweet features Nautilus founder, Parag Mallick's essay for the United Nations Conference on Trade and Development.

 

In his essay for the United Nations Conference on Trade and Development, Parag shares “Why proteins may help solve existential crises in healthcare, food security, and climate.” 

Screenshot of a Tweet from the Nautilus Biotechnology Twitter account. This tweet features the Nautilus founders' interview with BIOS Builders.

 

In this interview with BIOS, Sujal and Parag team up to discuss the inception of Nautilus, why now is the time for the proteomics revolution, and how they think Nautilus will change the world.

Screenshot of a tweet from the Nautilus Biotechnology Twitter account. This tweet features Parag Mallick's recent interview with ASBMB.

 

In this interview with ASBMB, Parag describes the technology underlying the Nautilus platform and expands on his vision to democratize access to the proteome.

Tweets focused on diversity, cross-disciplinary thinking, and the scientific workforce

At Nautilus we recognize the incredible value that comes from bridging diverse perspectives. We strive to include diverse voices in our decision making and these tweets highlight some of the ways diversity and cross-disciplinary thinking drive us. 

Screenshot of a Tweet from the Nautilus Biotechnology Twitter account. This tweet features Nautilus' summer interns from the SMASH program.

 

We recently worked with SMASH to empower the next generation of scientists and engineers of color and had the pleasure of hosting 6 talented SMASH summer interns at our research HQ. 

Screen shot of a tweet from the Nautilus Biotechnology Twitter account. This tweet features Parag Mallick's interview on the "Science in Society" podcast.

 

As a guest on the “Science in Society” podcast, Nautilus Chief Scientist, Parag Mallick, discusses how interdisciplinary thinking helped him come up with the idea behind Nautilus’ technology and expands upon his goal to democratize the proteome. 

Screenshot of a tweet from the Nautilus Biotechnology Twitter account. This tweet features Parag Mallick's recent article in "Vanish" magazine.

 

Parag is also a professionally trained magician. In a recent piece for “Vanish” magazine, Parag discusses the many ways scientists and magicians can learn from one another and thereby improve their crafts. 

Like what you see? Follow us @NautilusBio

That’s just a small sample of the many exciting things we share on our Twitter feed. We encourage you to follow us for more updates on our technology, the broader proteomics revolution, open positions at Nautilus, and much more! 

Browse by topic

  • Nautilus in the News
  • Events
  • Research and collaborations
  • Nautilus and our Platform
  • Proteomics
  • Life at Nautilus
  • Industry Interviews
SUBSCRIBE
Back To Blog

Nautilus Biotechnology

 

Corporate Headquarters
2701 Eastlake Avenue East
Seattle, WA 98102

 

Research Headquarters
835 Industrial Road, Suite 200
San Carlos, CA 94070

 

     

+1 (206) 333-2001

© 2022 Nautilus Biotechnology Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

We use cookies in order to continually improve your experience on our website. By clicking “Accept cookies” or clicking on any content on our site, you are consenting to our use of cookies as described in our Privacy Policy. You can opt-out if you wish. Accept Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT